IniciGrupsConversesMésTendències
Cerca al lloc
Aquest lloc utilitza galetes per a oferir els nostres serveis, millorar el desenvolupament, per a anàlisis i (si no has iniciat la sessió) per a publicitat. Utilitzant LibraryThing acceptes que has llegit i entès els nostres Termes de servei i política de privacitat. L'ús que facis del lloc i dels seus serveis està subjecte a aquestes polítiques i termes.
Hide this

Resultats de Google Books

Clica una miniatura per anar a Google Books.

Who Expert Committee on Specifications for…
S'està carregant…

Who Expert Committee on Specifications for Pharmaceutical Preparations:… (edició 2009)

de World Health Organization

MembresRessenyesPopularitatValoració mitjanaConverses
29No n'hi ha cap642,092No n'hi ha capNo n'hi ha cap
The Expert Committee on Specifications for Pharmaceutical Preparations works towards clear, independent and practical standards and guidelines for medicines' quality assurance. Standards are developed by the Committee through worldwide consultation and an international consensus building process. The forty-second meeting adopted 11 new monographs for inclusion in The International Pharmacopoeia (Ph.Int.) and seven related new International Chemical Reference Standards (ICRS). The specifications currently developed are internationally applicable test methodologies for antimalarial, antituberculosis, antiretroviral and specifically also medicines for children. The main principles for selection of INNs for biologicals were endorsed. In order to serve the WHO-managed Prequalification Programme, two new procedures were adopted, namely on prequalification of intrauterine devices (IUDs) and of male latex condoms, together with a new guidance on the assessment of active pharmaceutical ingredients for use in medicines. The international guidelines, specifications and nomenclature developed under the aegis of the Expert Committee on Specifications for Pharmaceutical Preparations serve all Member States, international organizations, United Nations agencies, regional and interregional harmonization efforts, and underpin important initiatives, including the prequalification of medicines, the Roll Back Malaria Programme, Stop TB, essential medicines and medicines for children. The advice and recommendations provided by this Expert Committee are intended to help national and regional authorities (in particular DRAs), procurement agencies, as well as major international bodies and institutions, such as the Global Fund to Fight AIDS, Tuberculosis and Malaria, and international organizations such as the United Nations Children's Fund (UNICEF) to combat problems of counterfeit and substandard medicines and to fill the gap for medicines used in the treatment of large populations, for which no international quality requirements are publicly available. WHO through this Expert Committee and with the help of many Member States' direct and indirect contributions, develops independent international standards through worldwide consultation and an international consensus building process. These are free for use and are developed by WHO with no commercial interest. Special efforts are made to keep their implementation costs low, but without compromising the quality, for example by reducing the number of physical reference standards needed for a Ph.Int. monograph to a minimum. These independent quality standards and guidelines will enable Member States and other parties to meet the challenges created by increasing globalization and to help ensure that all, including poor patient populations will receive quality medicines. The following new standards and guidelines were adopted and recommended for use List of available International Chemical Reference Substances and International Infrared Reference Spectra (Annex 1) 2. Procedure for assessing the acceptability, in principle, of male latex condoms for purchase by United Nations and other agencies (Annex 2) 3. Procedure for assessing the acceptability, in principle, of TCu380A intrauterine devices for purchase by United Nations and other agencies (Annex 3) 4. Active Pharmaceutical Ingredient Master File (APIMF) (Annex 4) 5. Main principles for selection of INNs for biologicals (Annex 5)… (més)
Membre:whocheck
Títol:Who Expert Committee on Specifications for Pharmaceutical Preparations: Forty-Third Report (Technical Report Series)
Autors:World Health Organization
Informació:World Health Organization (2009), Paperback, 152 pages
Col·leccions:La teva biblioteca
Valoració:
Etiquetes:No n'hi ha cap

Detalls de l'obra

WHO Expert Committee on Specifications for Pharmaceutical Preparations: 35th Report: Thirty-fifth Report (Technical Report Series) de World Health Organization

No n'hi ha cap
S'està carregant…

Apunta't a LibraryThing per saber si aquest llibre et pot agradar.

No hi ha cap discussió a Converses sobre aquesta obra.

Sense ressenyes
Sense ressenyes | afegeix-hi una ressenya
Has d'iniciar sessió per poder modificar les dades del coneixement compartit.
Si et cal més ajuda, mira la pàgina d'ajuda del coneixement compartit.
Títol normalitzat
Títol original
Títols alternatius
Data original de publicació
Gent/Personatges
Llocs importants
Esdeveniments importants
Pel·lícules relacionades
Premis i honors
Epígraf
Dedicatòria
Primeres paraules
Citacions
Darreres paraules
Nota de desambiguació
Editor de l'editorial
Creadors de notes promocionals a la coberta
Llengua original
CDD/SMD canònics

Referències a aquesta obra en fonts externes.

Wikipedia en anglès

No n'hi ha cap

The Expert Committee on Specifications for Pharmaceutical Preparations works towards clear, independent and practical standards and guidelines for medicines' quality assurance. Standards are developed by the Committee through worldwide consultation and an international consensus building process. The forty-second meeting adopted 11 new monographs for inclusion in The International Pharmacopoeia (Ph.Int.) and seven related new International Chemical Reference Standards (ICRS). The specifications currently developed are internationally applicable test methodologies for antimalarial, antituberculosis, antiretroviral and specifically also medicines for children. The main principles for selection of INNs for biologicals were endorsed. In order to serve the WHO-managed Prequalification Programme, two new procedures were adopted, namely on prequalification of intrauterine devices (IUDs) and of male latex condoms, together with a new guidance on the assessment of active pharmaceutical ingredients for use in medicines. The international guidelines, specifications and nomenclature developed under the aegis of the Expert Committee on Specifications for Pharmaceutical Preparations serve all Member States, international organizations, United Nations agencies, regional and interregional harmonization efforts, and underpin important initiatives, including the prequalification of medicines, the Roll Back Malaria Programme, Stop TB, essential medicines and medicines for children. The advice and recommendations provided by this Expert Committee are intended to help national and regional authorities (in particular DRAs), procurement agencies, as well as major international bodies and institutions, such as the Global Fund to Fight AIDS, Tuberculosis and Malaria, and international organizations such as the United Nations Children's Fund (UNICEF) to combat problems of counterfeit and substandard medicines and to fill the gap for medicines used in the treatment of large populations, for which no international quality requirements are publicly available. WHO through this Expert Committee and with the help of many Member States' direct and indirect contributions, develops independent international standards through worldwide consultation and an international consensus building process. These are free for use and are developed by WHO with no commercial interest. Special efforts are made to keep their implementation costs low, but without compromising the quality, for example by reducing the number of physical reference standards needed for a Ph.Int. monograph to a minimum. These independent quality standards and guidelines will enable Member States and other parties to meet the challenges created by increasing globalization and to help ensure that all, including poor patient populations will receive quality medicines. The following new standards and guidelines were adopted and recommended for use List of available International Chemical Reference Substances and International Infrared Reference Spectra (Annex 1) 2. Procedure for assessing the acceptability, in principle, of male latex condoms for purchase by United Nations and other agencies (Annex 2) 3. Procedure for assessing the acceptability, in principle, of TCu380A intrauterine devices for purchase by United Nations and other agencies (Annex 3) 4. Active Pharmaceutical Ingredient Master File (APIMF) (Annex 4) 5. Main principles for selection of INNs for biologicals (Annex 5)

No s'han trobat descripcions de biblioteca.

Descripció del llibre
Sumari haiku

Dreceres

Cobertes populars

Valoració

Mitjana: Sense puntuar.

Ets tu?

Fes-te Autor del LibraryThing.

 

Quant a | Contacte | LibraryThing.com | Privadesa/Condicions | Ajuda/PMF | Blog | Botiga | APIs | TinyCat | Biblioteques llegades | Crítics Matiners | Coneixement comú | 157,069,277 llibres! | Barra superior: Sempre visible